Halozyme Therapeutics director Matthew Posard sells $482,146 in stock



[
Halozyme Therapeutics director Matthew Posard sells $482,146 in stock
[og_img]
https://www.investing.com/news/insider-trading-news/halozyme-therapeutics-director-matthew-posard-sells-482146-in-stock-93CH-5037392


Investing.com

Latest articles

spot_imgspot_img

Related articles

Leave a reply

Please enter your comment!
Please enter your name here

spot_imgspot_img